HAEMONETICS CORP — Director's Dealing 2011

Nov 1, 2011

SEC Form 4/A — Form 4/A

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2011-10-25

Reporting Person: Jesse Sandra (VP & CLO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-10-25	Non-Qualified Stock Option (right to buy)	$61.34	A	15370.0	Acquired	2018-10-25	Common Stock (15370.0)	Direct

Footnotes

F1: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.